Pharmacotherapeutical options in inflammatory bowel disease: an update

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Pharmacy World & Science

• Publication date

  2001-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1011268302386PMID 11344586
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease.

  2000cited by this paper
• Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma.

  2000cited by this paper
• Etiology and pathophysiology of inflammatory bowel disease--environmental factors.

  2000cited by this paper
• REVIEW: Antibacterial Therapy for Crohn's Disease: A Review Emphasizing Therapy Directed Against Mycobacteria

  2000cited by this paper
• A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.

  2000cited by this paper
• Regular review: Ulcerative colitis

  2000cited by this paper
• Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.

  1999cited by this paper
• Is mycophenolate mofetil a new alternative in the treatment of inflammatory bowel disease?

  1999cited by this paper
• The pill: safe sex and Crohn’s disease?

  1999cited by this paper
• New life in a sleeper: thalidomide and Crohn's disease.

  1999cited by this paper
• Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

  1999cited by this paper
• Inflammatory bowel disease approaching the 3rd millennium: pathogenesis and therapeutic implications?

  1999cited by this paper
• Oral contraceptive use and the clinical course of Crohn’s disease: a prospective cohort study

  1999cited by this paper
• Current theories on the causes of inflammatory bowel disease.

  1999cited by this paper
• Effects of current and former cigarette smoking on the clinical course of Crohn’s disease

  1999cited by this paper
• An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.

  1999cited by this paper
• Crohn’s disease severity in familial and sporadic cases

  1999cited by this paper
• Azathioprine for maintaining remission of Crohn's disease.

  1998cited by this paper
• Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.

  1998cited by this paper
• Management of recurrent Crohn's disease.

  1998cited by this paper
• Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn’s disease

  1998cited by this paper
• Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease.

  1997cited by this paper
• Colitis induced by non-steroidal anti-inflammatory drugs.

  1997cited by this paper
• A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

  1997cited by this paper
• A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

  1997cited by this paper
• [Nutrition in the etiopathogenesis of chronic inflammatory bowel diseases].

  1997cited by this paper
• Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis.

  1996cited by this paper
• Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.

  1996cited by this paper
• Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.

  1995cited by this paper
• Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine

  1995cited by this paper
• Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease.

  1995cited by this paper
• Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study.

  1995cited by this paper
• Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis.

  1995cited by this paper
• A controlled double blind study of azathioprine in the management of Crohn's disease.

  1995cited by this paper
• A comparison of budesonide with prednisolone for active Crohn's disease.

  1994cited by this paper
• New developments in the pharmacotherapy of inflammatory bowel disease

  1992cited by this paper
• Colitis induced by nonsteroidal anti-inflammatory drugs. Report of four cases and review of the literature.

  1992cited by this paper
• Long-term treatment of Crohn's disease with cyclosporine: the effect of a very low dose on maintenance of remission.

  1991cited by this paper
• A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

  1989cited by this paper
• Non-steroidal anti-inflammatory drug-induced disease in the distal ileum and large bowel.

  1989cited by this paper
• Toxicity of nonsteroidal anti-inflammatory drugs.

  1989cited by this paper
• Geographic and temporal variations of sugar and margarine consumption in relation to Crohn's disease.

  1988cited by this paper
• Familial incidence of Crohn's disease in The Netherlands and a review of the literature.

  1984cited by this paper
• Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study.

  1980cited by this paper
• [Non-steroidal anti-inflammatory drug].

  1975cited by this paper

• Anti-Inflammatory Effects of an Extract of Polygonum hydropiper Stalks on 2,4,6-Trinitrobenzenesulphonic Acid-Induced Intestinal Inflammation in Rats by Inhibiting the NF-κB Pathway

  2018cites this paper
• Red bean extracts protect rats against intestinal inflammatory damage

  2016cites this paper
• Oregano Essential Oil Improves Intestinal Morphology and Expression of Tight Junction Proteins Associated with Modulation of Selected Intestinal Bacteria and Immune Status in a Pig Model

  2016cites this paper
• Anti-inflammatory effects of Citrus sinensis L., Citrus paradisi L. and their combinations.

  2016cites this paper
• Intestinal anti-inflammatory activity of the seeds of Raphanus sativus L. in experimental ulcerative colitis models.

  2016cites this paper
• Catechin-7-O-β-D-glucopyranoside isolated from the seed of Phaseolus calcaratus Roxburgh ameliorates experimental colitis in rats.

  2015cites this paper
• Therapeutic efficacy and mechanism of Zhenrenyangzang decoction in rats with experimental ulcerative colitis.

  2015cites this paper
• Molecular Mechanisms of Action and Therapeutic Uses of Pharmacological Inhibitors of HIF–Prolyl 4-Hydroxylases for Treatment of Ischemic Diseases

  2014cites this paper
• Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis.

  2013cites this paper
• Ulcerative Colitis Impairs the Acylethanolamide-Based Anti-Inflammatory System Reversal by 5-Aminosalicylic Acid and Glucocorticoids

  2012cites this paper
• Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activation

  2011cites this paper
• Gastrointestinal strongyloidiasis in immunocompromised patients: a case report.

  2011cites this paper
• Omega-3 fatty acids in the maintenance of ulcerative colitis

  2010cites this paper
• Protective effect of ilomastat on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats.

  2008cites this paper
• Rectal administration of d-alpha tocopherol for active ulcerative colitis: a preliminary report.

  2008cites this paper
• A new method for targeted drug delivery using polymeric microcapsules

  2007cites this paper
• Effects of a Combination of Thyme and Oregano Essential Oils on TNBS-Induced Colitis in Mice

  2007cites this paper
• Mycophenolate mofetil therapy for refractory inflammatory bowel disease

  2007cites this paper
• Strongyloides stercoralis infestation in a patient with severe ulcerative colitis.

  2006cites this paper
• Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis.

  2006cites this paper
• Current Therapy of Inflammatory Bowel Disease in Children

  2006cites this paper
• Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome.

  2004cites this paper
• Efficacy of conventional immunosuppressive drugs in IBD.

  2004cites this paper
• Mechanisms of Natural Tolerance in the Intestine: Implications for Inflammatory Bowel Disease

  2004cites this paper
• The intestinal anti‐inflammatory effect of quercitrin is associated with an inhibition in iNOS expression

  2004cites this paper
• Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis model.

  2003cites this paper
• CD44v7 interferes with activation‐induced cell death by up‐regulation of anti‐apoptotic gene expression

  2003cites this paper
• The Intestinal Anti-inflammatory Activity of UR-12746S on Reactivated Experimental Colitis Is Mediated Through Downregulation of Cytokine Production

  2003cites this paper
• CD 44 v 7 interferes with activation-induced cell death by up-regulation of antiapoptotic gene expression

  2003cites this paper